Bellanti F - Search Results

1

Alteration of circulating redox balance in coronavirus disease-19-induced acute respiratory distress syndrome.

Bellanti F, Kasperczyk S, Kasperczyk A, Dobrakowski M, Pacilli G, Vurchio G, Maddalena A, Quiete S, Lo Buglio A, Capurso C, Serviddio G, Vendemiale G. Bellanti F, et al. J Intensive Care. 2023 Jul 5;11(1):30. doi: 10.1186/s40560-023-00679-y. J Intensive Care. 2023. PMID: 37408073 Free PMC article.

2

Sampling Optimization in Pharmacokinetic Bridging Studies: Example of the Use of Deferiprone in Children With β-Thalassemia.

Bellanti F, Di Iorio VL, Danhof M, Della Pasqua O. Bellanti F, et al. J Clin Pharmacol. 2016 Sep;56(9):1094-103. doi: 10.1002/jcph.708. Epub 2016 Apr 1. J Clin Pharmacol. 2016. PMID: 26785826 Clinical Trial.

3

Integration of PKPD relationships into benefit-risk analysis.

Bellanti F, van Wijk RC, Danhof M, Della Pasqua O. Bellanti F, et al. Br J Clin Pharmacol. 2015 Nov;80(5):979-91. doi: 10.1111/bcp.12674. Epub 2015 Jul 29. Br J Clin Pharmacol. 2015. PMID: 25940398 Free PMC article. Review.

4

Modelling and simulation as research tools in paediatric drug development.

Bellanti F, Della Pasqua O. Bellanti F, et al. Eur J Clin Pharmacol. 2011 May;67 Suppl 1(Suppl 1):75-86. doi: 10.1007/s00228-010-0974-3. Epub 2011 Jan 19. Eur J Clin Pharmacol. 2011. PMID: 21246352 Free PMC article. Review.

5

Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?

Bellanti F, Kågedal B, Della Pasqua O. Bellanti F, et al. Eur J Clin Pharmacol. 2011 May;67 Suppl 1(Suppl 1):87-107. doi: 10.1007/s00228-010-0966-3. Epub 2011 Feb 2. Eur J Clin Pharmacol. 2011. PMID: 21287160 Free PMC article. Review.

6

Population pharmacokinetic and exposure-response analyses from ALTA-1L: Model-based analyses supporting the brigatinib dose in ALK-positive NSCLC.

Gupta N, Reckamp KL, Camidge DR, Kleijn HJ, Ouerdani A, Bellanti F, Maringwa J, Hanley MJ, Wang S, Zhang P, Venkatakrishnan K. Gupta N, et al. Among authors: bellanti f. Clin Transl Sci. 2022 May;15(5):1143-1154. doi: 10.1111/cts.13231. Epub 2022 Feb 8. Clin Transl Sci. 2022. PMID: 35041775 Free PMC article.

7

Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder.

Singh P, Gao X, Kleijn HJ, Bellanti F, Pelto R. Singh P, et al. Among authors: bellanti f. Front Neurol. 2021 Nov 3;12:696387. doi: 10.3389/fneur.2021.696387. eCollection 2021. Front Neurol. 2021. PMID: 34803867 Free PMC article.

8

Prediction of thyroid C-cell carcinogenicity after chronic administration of GLP1-R agonists in rodents.

van den Brink W, Emerenciana A, Bellanti F, Della Pasqua O, van der Laan JW. van den Brink W, et al. Among authors: bellanti f. Toxicol Appl Pharmacol. 2017 Apr 1;320:51-59. doi: 10.1016/j.taap.2017.02.010. Epub 2017 Feb 16. Toxicol Appl Pharmacol. 2017. PMID: 28213092

9

Population pharmacokinetics of deferiprone in healthy subjects.

Bellanti F, Danhof M, Della Pasqua O. Bellanti F, et al. Br J Clin Pharmacol. 2014 Dec;78(6):1397-406. doi: 10.1111/bcp.12473. Br J Clin Pharmacol. 2014. PMID: 25052529 Free PMC article.

10

Model-Based Optimisation of Deferoxamine Chelation Therapy.

Bellanti F, Del Vecchio GC, Putti MC, Cosmi C, Fotzi I, Bakshi SD, Danhof M, Della Pasqua O. Bellanti F, et al. Pharm Res. 2016 Feb;33(2):498-509. doi: 10.1007/s11095-015-1805-0. Epub 2015 Nov 10. Pharm Res. 2016. PMID: 26555666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page